Biogen Inc. buy Royal Bank of Canada
Start price
29.05.24
/
50%
€195.00
Target price
29.05.25
€292.88
Performance (%)
9.69%
Price
17:44
€213.90
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 9.69%. This prediction currently runs until 29.05.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -0.144% | -0.144% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $317.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat